Frontline Pharma: Sarah O’Keeffe
By James Strachan
May 8, 2026
Ahead of HPLC 2026, Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients
11 min read
False
By James Strachan
May 8, 2026
Ahead of HPLC 2026, Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients
11 min read
April 28, 2026
Patient-derived tumor explants reveal uneven PARP inhibitor uptake, with lysosomes acting as reservoirs for some weak-base drugs
3 min read
April 14, 2026
ICP-MS method enables early, quantitative metabolite analysis without radiolabels
2 min read
April 14, 2026
Experts explore how analytical science is meeting the challenges shaping GLP-1 therapeutics
1 min read
April 13, 2026
Comprehensive review highlights label-free viral detection – and the hurdles to real-world deployment
2 min read
By James Strachan
April 10, 2026
A new series championing scientists in the pharmaceutical industry begins with Genentech’s rising star
5 min read
April 6, 2026
Jonathan Maurer of the University of Geneva discusses his work with Sanofi and Waters – and why good analytical science has a lot in common with good cooking
3 min read
By Fabrice Gritti
March 18, 2026
How physics-informed machine learning can more accurately predict retention times in LC and speed up drug development
7 min read
By Michelle Sestak
March 16, 2026
A look at the potential of Raman spectroscopy in biopharma – and what else lies on the horizon for this important technique
3 min read
March 13, 2026
Spectroscopic analysis reveals lipid–RNA interactions governing nanoparticle formulation efficiency
2 min read
False
False
Affiliations:
Specialties:
Areas of Expertise:
False